Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|July 26, 2024
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trialSoo Heon Kwak, Kyung Ah Han, Eun Sook Kim, et al.
Diabetes, Obesity & Metabolism|July 9, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 studyKyung Ah Han, You-Cheol Hwang, Shin Je Moon, et al.
Diabetes, Obesity & Metabolism|April 28, 2017
Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exerciseJuri Park, Sung Woo Park, Kun Ho Yoon, et al.
Diabetes & Metabolism Journal|September 26, 2023
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week ExtensionJun Sung Moon, Il Rae Park, Hae Jin Kim, et al.
The Clinical Journal of Pain|February 27, 2022
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 TrialKyung Ah Han, Yong-Ho Lee, Hyun-Shik Son, et al.
Diabetes, Obesity & Metabolism|December 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trialSeung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2016
Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled TrialSang-Man Jin, Kyung Ah Han, Jae Myung Yu, et al.
Neuron|February 19, 2026
Juvenile-to-adult refinement of thalamic reticular circuits via LRRTM3 enables high-resolution sensory encodingDongsu Lee, Kyung Ah Han, Hyeonyeong Jeong, et al.
Diabetes, Obesity & Metabolism|March 26, 2026
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III TrialSoo Lim, Tae Nyun Kim, Ji Oh Mok, et al.
Diabetes, Obesity & Metabolism|December 28, 2016
Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study)Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, et al.
Pageof 8